Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

1.
3.

Prospectively randomized trial using perioperative low dose octreotide to prevent organ related and general complications following pancreatic surgery and pancreatico-jejunostomy.

Hesse UJ, De Decker C, Houtmeyers P, Demetter P, Ceelen W, Pattyn P, Troisi R, de Hemptinne B.

Acta Chir Belg. 2005 Aug;105(4):383-7.

PMID:
16184721
4.

Prophylactic octreotide and delayed gastric emptying after pancreaticoduodenectomy: results of a prospective randomized double-blinded placebo-controlled trial.

Kollmar O, Moussavian MR, Richter S, de Roi P, Maurer CA, Schilling MK.

Eur J Surg Oncol. 2008 Aug;34(8):868-75. doi: 10.1016/j.ejso.2008.01.014. Epub 2008 Mar 4.

PMID:
18299182
5.

Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review.

Lai EC, Lau SH, Lau WY.

Arch Surg. 2009 Nov;144(11):1074-80. doi: 10.1001/archsurg.2009.193. Review.

PMID:
19917946
6.

[Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].

Briceño Delgado FJ, López Cillero P, Rufián Peña S, Solórzano Peck G, Miño Fugarolas G, Pera Madrazo C.

Rev Esp Enferm Dig. 1998 Oct;90(10):687-94. Spanish.

PMID:
9824933
7.

Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.

Vanounou T, Pratt WB, Callery MP, Vollmer CM Jr.

J Am Coll Surg. 2007 Oct;205(4):546-57. Epub 2007 Aug 23.

PMID:
17903728
8.

Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.

Barnett SP, Hodul PJ, Creech S, Pickleman J, Arahna GV.

Am Surg. 2004 Mar;70(3):222-6; discussion 227.

PMID:
15055845
9.

Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.

Droeser RA, Jeanmonod P, Schuld J, Moussavian MR, Schilling MK, Kollmar O.

Dig Surg. 2012;29(6):484-91. doi: 10.1159/000345874. Epub 2013 Jan 31.

10.

Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease.

Lowy AM, Lee JE, Pisters PW, Davidson BS, Fenoglio CJ, Stanford P, Jinnah R, Evans DB.

Ann Surg. 1997 Nov;226(5):632-41. Review.

11.

The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.

Hesse UJ, Meester D, Troisi R, Cathenis K, Lameire N, Hemptinne B.

Clin Transplant. 2005 Jun;19(3):299-303.

PMID:
15877788
12.

[Management of postoperative pancreatic fistula resistant to octreotide therapy].

Dobosz M, Dymecki D, Babicki A, Hać S, Gruca Z, Wajda Z.

Wiad Lek. 2001;54(7-8):380-5. Polish.

PMID:
11641892
13.

Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial.

Suc B, Msika S, Piccinini M, Fourtanier G, Hay JM, Flamant Y, Fingerhut A, Fagniez PL, Chipponi J; French Associations for Surgical Research.

Arch Surg. 2004 Mar;139(3):288-94; discussion 295.

PMID:
15006886
14.

Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy.

Poon RT, Lo SH, Fong D, Fan ST, Wong J.

Am J Surg. 2002 Jan;183(1):42-52.

PMID:
11869701
15.

Risk factors of pancreatic fistula following pancreaticoduodenectomy for periampullary cancer.

Popiela T, Kedra B, Sierzega M, Gurda A.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1484-8.

PMID:
15362783
16.

Postoperative pancreatic fistula following distal pancreatectomy for pancreatic neoplasm; can pancreatic fistula be prevented?

Okabayashi T, Kobayashi M, Sugimoto T, Namikawa T, Okamoto K, Hokimoto N, Araki K.

Hepatogastroenterology. 2004 Nov-Dec;51(60):1838-41.

PMID:
15532838
17.

Economic evaluation of the use of octreotide for prevention of complications following pancreatic resection.

Rosenberg L, MacNeil P, Turcotte L.

J Gastrointest Surg. 1999 May-Jun;3(3):225-32.

PMID:
10481115
18.

Pancreatic fistula after distal pancreatectomy: predictive risk factors and value of conservative treatment.

Pannegeon V, Pessaux P, Sauvanet A, Vullierme MP, Kianmanesh R, Belghiti J.

Arch Surg. 2006 Nov;141(11):1071-6; discussion 1076.

PMID:
17116799
19.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

20.

Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution.

Goh BK, Tan YM, Chung YF, Cheow PC, Ong HS, Chan WH, Chow PK, Soo KC, Wong WK, Ooi LL.

Arch Surg. 2008 Oct;143(10):956-65. doi: 10.1001/archsurg.143.10.956.

PMID:
18936374

Supplemental Content

Support Center